Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2007-09-11
2007-09-11
Kemmerer, Elizabeth C. (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C530S350000, C530S402000
Reexamination Certificate
active
10122026
ABSTRACT:
Disclosed are novel compositions of morphogenic proteins constituting soluble forms of these proteins, antibodies that distinguish between soluble and mature forms, and method for producing these morphogenic proteins and antibodies.
REFERENCES:
patent: 4294753 (1981-10-01), Urist
patent: 4455256 (1984-06-01), Urist
patent: 4465669 (1984-08-01), Wissler et al.
patent: 4619989 (1986-10-01), Urist
patent: 4857456 (1989-08-01), Urist
patent: 5106748 (1992-04-01), Wozney et al.
patent: 5141905 (1992-08-01), Rosen et al.
patent: 5168050 (1992-12-01), Hammonds, Jr. et al.
patent: 5393739 (1995-02-01), Bentz et al.
patent: 5650276 (1997-07-01), Smart et al.
patent: 5656593 (1997-08-01), Kuberasampath et al.
patent: 5674844 (1997-10-01), Kuberasampath et al.
patent: 5733878 (1998-03-01), Kuberasampath et al.
patent: 5739107 (1998-04-01), Cohen et al.
patent: 5834179 (1998-11-01), Jones et al.
patent: 6022853 (2000-02-01), Kuberasampath et al.
patent: 6071708 (2000-06-01), Jones et al.
patent: 6395883 (2002-05-01), Jones et al.
patent: 6399569 (2002-06-01), Cohen et al.
patent: 6495513 (2002-12-01), Rueger et al.
patent: 0416578 (1996-07-01), None
patent: 1989/09787 (1989-10-01), None
patent: 1989/09788 (1989-10-01), None
patent: 1989/10409 (1989-11-01), None
patent: 1991/05802 (1991-05-01), None
patent: 1991/18047 (1991-11-01), None
patent: 1992/07073 (1992-04-01), None
patent: 1993/05751 (1993-04-01), None
Gentry et al., 1990, Biochemistry 29:6851-6857.
Lyons et al., 1989, PNAS USA 86:4554-4558.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Wells, 1990, Biochemistry 29:8509-8517.
Bork, 2000, Genome Research 10:398-400.
Skolnick et al., 2000, Trends in Biotech. 18(1):34-39.
Doerks et al., 1998, Trends in Genetics 14:248-250.
Smith et al., 1997, Nature Biotechnology 15:1222-1223.
Brenner, 1999, Trends in Genetics 15:132-133.
Bork et al., 1996, Trends in Genetics 12:425-427.
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”,Science, 247:1306-1310 (1987).
Celeste et al., “Identification of Transforming Growth Factor β Family Members Present in Bone-Inductive Protein Purified from Bovine Bone”, Proc. Natl. Acad. Sci., USA, 87:9843-9847 (1990).
Gentry et al., “The Pro Domain of Pre-Pro-Transforming Growth Factor β1 When Independently Expressed is a Functional Binding Protein for the Mature Growth Factor”,Biochemistry, 29:6851-6857 (1990).
Hammonds Jr., et al., “Bone-Inducing Activity of Mature BMP-2b Produced from a Hybrid BMP-2a/2b Precursor”,Mol. Endocrin. 5:149-155 (1991).
Israel et al., “Expression of Recombinant BMP-2 in Chinese Hamster Ovary Cells”, J. Cell. Biochem. Abstr. (Q111), p. 168.
Israel et al., “Expression and Characterization of Bone Morphogenic Protein-2 in Chinese Hamster Ovary Cells”, Growth Factors, 7: 139-150 (1992).
Lee, “Expression of Growth/Differentiation Factor 1 in the Nervous System: Conservation of a Bicistronic Structure”, Proc. Natl. Acad. Sci., 88: 4250-4254 (1991).
Lyons et al., “Vgr-1, a Mammalian Gene Related toXenopusVg-1, is a Member of the Transforming Growth Factor β Gene Superfamily”, Proc. Natl. Acad. Sci., USA, 86: 4554-4558 (1989).
Lyons et al., “Transforming Growth Factors and the Regulation of Cell Proliferation”,Eur. J. Biochem. 187:467-473 (1990).
Massague, “The TGF-β Family of Growth and Differentiation Factors”,Cell, 49:437-438 (1987).
Ngo et al., “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox”,The Protein Folding Problem and Tertiary Structure Prediction, Ch. 14, pp. 492-494 (1994).
Özkaynak et al., “OP-1 cDNA Encodes an Osteogenic Protein in the TGF-β Family”,The EMBO J., 9:2085-2093 (1990).
Panganiban et al., “Biochemical Characterization of theDrosophila dppProtein, a Member of the Transforming Growth Factor β Family of Growth Factors”,Mol. and Cellul. Biol., 10: 2669-2677 (1990).
Pepinsky et al., “Proteolytic Processing of Mullerian Inhibiting Substance Produces a Transforming Growth Factor-β-like Fragment”,J. Biol. Chem. 263:18961-18964 (1988).
Rudinger, “Characteristics of the Amino Acids as Components of Peptide Hormone Sequence”,Peptide Hormones, pp. 1-6 (1976).
Turing, “The Chemical Basis of Morphogenesis”,Phil. Trans. Roy. Soc. B237:37-39 (1952).
Urist et al., “Radioimmunoassay of Bone Morphogenetic Protein in Serum: A Tissue-Specific Parameter of Bone Metabolism”,Pro. Soc. for Exper. Bio. Med., 176:472-475 (1984).
Wakefield et al., “Recombinant Latent Transforming Growth Factor β 1 has a Longer Plasma Half-Like in Rats than Active Transforming Growth Factor β 1, and a Different Tissue Distribution”,J. of Clin. Invest., 86:1976-1984 (1990).
Wang et al., “Purification and Characterization of Other Distinct Bone-Inducing Factors”, Proc. Natl. Acad. Sci., USA, 85:9484-9488 (1988).
Wang et al., “Recombinant Human Bone Morphogenetic Protein Induces Bone Formation”, Proc. Natl. Acad. Sci., 87: 2220-2224 (1990).
Weeks et al., “A Maternal mRNA Localized to the Vegetal Hemisphere inXenopusEggs Codes for a Growth Factor Related to TGF-β”Cell51:861-867 (1987).
Wharton et al., “Drosphila60A Gene, Another Transforming Growth Factor β Family Member, is Closely Related to Human Bone Morphogenetic Proteins”, Proc. Natl. Acad. Sci., 88:9214-9218 (1991).
Wilkins, “What's in a (biological) term? Frequently, a Great Deal of Ambiguity”,BioEssays, 17:375-377 (1995).
Wozney et al., “Novel Regulators of Bone Formation: Molecular Clones and Activities”Science, 242: 1528-1533 (1988).
Doctor, et al., “Seqence, Biochemical Characterization, and Developmental Expression of a New Member of the TFG-β Superfamily inDrosophila melanogaster”, Developmental Biology, 151:491-505 (1992).
Brunner et al., “Site-directed Mutagenesis of Cysteine Residues in the Pro Region of the Transforming Growth Factor β 1 Precursor”,Jour. Of Biological Chemistry, 264:23:13660-13664 (1989).
Jones William K.
Kubersmith Thangavel
Oppermann Hermann
Ozkaynak Engin
Rueger David C.
Kemmerer Elizabeth C.
Kirkpatrick & Lockhart Preston Gates & Ellis LLP
Stryker Corporation
LandOfFree
Morphogen solubilizing peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Morphogen solubilizing peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morphogen solubilizing peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3790065